Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2247-2251

  Osman, Iman ^a   Scher, Howard ^a   Zhang, Zuo Feng ^a   Soos, Timothy J ^a   Hamza, Reda ^b   Eissa, Saad ^b   Khaled, Hussien ^b   Koff, Andrew ^a   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN E;

ADENOCARCINOMA; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CELL CYCLE; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHISTOSOMIASIS; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYCLIN A; CYCLIN D1; CYCLIN E; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; SCHISTOSOMIASIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0031408598     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Khaled, H. M. Bladder cancer and bilharziasis today. Cancer J., 6: 65-71, 1993.
2. El-Bolkainy, M. N., Mokhtar, N. M., Ghoniem, M. A., and Hussien, M. H. The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer (Phila.), 48: 2643-2648, 1981.
3. El-Bolkainy, M. N., and Chu, E. W. Detection of Bladder Cancer Associated with Schistosomiasis. Cairo, Egypt: El Ahram Press, 1981.
4. Osman, I., Scher, H. I., Zhang, Z-F., Pellicer, I., Hamza, R., Eissa, S., Khaled, H., and Cordon-Cardo, C. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer. Clin. Cancer Res., 3: 531-536, 1997.
5. Cordon-Cardo, C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasms. Am. J. Pathol., 147: 545-560, 1995.
6. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
7. Bartakova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 355-361, 1994.
8. Scherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
9. Keyomarsi, K., Conte, D., Toyofuku, W., and Fox, M. P. Deregulation of cyclin E in breast cancer. Oncogene, 11: 941-950, 1995.
10. Nielsen, N. H., Emdin, S. O., Cajander, J., and Landberg, G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of retinoblastoma protein. Oncogene, 14: 295-304, 1997.
11. Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., de Fazio, A., Watts, C. K., Musgrove, E. A., Watts, A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
12. Schuuring, E., Verhoeven, E., Van de Vijer, M., Mool, W., and Michalides, R. Amplification of genes within the chromosome 11q13 is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52: 5229-5234, 1992.
13. Metha, C. R., and Patel, N. R. A network algorithm for performing Fisher's exact test in rXc contingency tables. J. Am. Stat. Assoc., 78: 427-434, 1983.
14. Landis, R., J., Hetman, E. R., and Koch, G. G. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int. Stat. Rev., 46: 237-254, 1978.
15. SAS/STAT User Guide, Version 6. Cary, NC: SAS Institute, Inc., 1990.
16. Welcker, M., Lukas, J., Strauss, M., and Bartek, J. Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. Oncogene, 13: 419-425, 1996.
17. Hall, M., and Peters, G. Adv. Cancer Res., 68: 67-108, 1996.
18. Tsutumi, M., Sakamoto, H., Yoshida, T., Kakizoe, T., Koiso, K., Sugimura, T., and Terada, M. Coamplification of the hst-1 and int-2 genes in human cancers. Jpn. J. Cancer Res., 79: 428-432, 1988.
19. Bringuier, P. P., Tamimi, Y., Schuuring, E., and Schalken, J. Expression of cyclin D1 and EMS1 in bladder tumors; relationship with chromosome 11q13 amplification. Oncogene, 12: 1747-1753, 1996.
20. Proctor, A. J., Coombs, L. M., Cairns, J. P., and Knowles, M. A. Amplification at chromosome 11q13 in transitional cell tumors of the bladder. Oncogene, 6: 789-795, 1991.
21. Theillet, C., Roy, X. L., Lapeyiere, O. D., Grosgeores, J., Adnane, J., Raynaud, S. D., Simony-Lafontaine, J., Goldfarb, M., Escot, C., and Gaudray, P. Amplification of FGE-related genes in human tumors: possible involvement of HST in breast carcinoma. Oncogene, 4: 915-922, 1989.
22. Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. Unscheduled expression of cyclin B1 and E in several leukemic and solid tumor cell lines. Cancer Res., 54: 4285-4288, 1994.
23. 1 in mammalian fibroblasts. Science (Washington DC), 239: 1908-1912, 1993.
24. 1 to S transition. Mol. Cell. Biol., 15: 3463-3469, 1995.
25. Ellis, A., Groden, J., Ye, T-Z., Straughen, J., Lennon, D., Ciocci, S., Proytcheva, M., and James, G. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell, 83: 655-666, 1995.
26. Uchimaru, K., Endo, K., Fujinuma, H., Zukerberg, L., Arnold, A., and Motokura, T. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation. Jpn. J. Cancer Res., 87: 459-465, 1996.